12.07.2015 Views

1999;100;1043-1049 Circulation Poss, Kalon K. L. Ho, Lynn E ...

1999;100;1043-1049 Circulation Poss, Kalon K. L. Ho, Lynn E ...

1999;100;1043-1049 Circulation Poss, Kalon K. L. Ho, Lynn E ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Lee et al Cardiac Risk Index for Major Noncardiac Surgery 1047Bars represent rate of major cardiac complicationsin entire patient population (both derivationand validation cohorts combined) forpatients in Revised Cardiac Risk Index classesaccording to type of procedure performed. AAAindicates abdominal aortic aneurysm. Note thatby definition, patients undergoing AAA, thoracic,and abdominal procedures wereexcluded from class I. In all subsets exceptpatients undergoing AAA, there was a statisticallysignificant trend toward greater risk withhigher risk class.therapy for diabetes (7/112; 6%), and preoperative serumcreatinine 2.0 mg/dL (9/103; 9%).Derivation of the Revised Cardiac Risk IndexA logistic regression model that included the 6 independentcorrelates of major cardiac complications indicated that theadjusted OR for these factors ranged from 1.9 to 3.0. Twoindexes were derived from this model. In the variable-weightindex, point values were assigned in proportion to the logisticregression model weights for each variable. In the equalweightmodel, 1 point was assigned to each variable. ROCanalysis showed no significant difference between the diagnosticperformances of the models (0.7650.032 versus0.7590.032, respectively; P0.28). Therefore, the RevisedCardiac Risk Index was constructed with each risk factorassigned 1 point.Patients with 0, 1, 2, or more factors were assigned to classesI, II, III, or IV, respectively; rates of major cardiac complicationsranged from 0.5% to 9% (Table 3). Statistically significant(P0.05) differences were found in rates of major cardiaccomplications between all classes. ROC analysis indicated thatthe diagnostic performance of the Revised Cardiac Risk Indexwas superior to all 3 of the prior decision aids.Validation of the Prediction RuleDiagnostic performance of the Revised Cardiac Risk Indexwas similar in the derivation and validation cohorts, asreflected in ROC analyses (Table 3). Within any specificclass of the Revised Cardiac Risk Index, the complicationrates were not statistically different between the derivationand validation cohorts. Within the validation cohort, therelative risk for patients in class II compared with patients inclass I (2.2 [95% CI 0.4, 11.0]) was not significantly differentfrom the corresponding relative risk in the derivation cohort(2.7 [95% CI 1.0, 7.5]).In the validation cohort, the outcome rate was significantlyhigher in class III than class II (6.6% versus 0.9%; P0.001).The relative risk of class III versus class II in the validationcohort (7.5 [95% CI 2.8, 20.0]) was not significantly differentfrom the corresponding relative risk in the derivation cohort(2.8 [95% CI 1.4, 5.6]) (P0.11).The difference between class IV and class III in outcomerates in the validation cohort did not reach statistical significance(11.0% versus 6.6%; P0.15). The relative risk ofclass IV versus class III in the validation cohort (1.7 [95% CI0.8, 3.4]) was not significantly different from the correspondingrelative risk in the derivation cohort (2.5 [95% CI 1.4,4.7]) (P0.38).Four of the factors in the Revised Cardiac Risk Index wereindependent correlates of major cardiac complications in thevalidation cohort: high-risk type of surgery, ischemic heartdisease, congestive heart failure, and history of cerebrovasculardisease. There were trends or significant univariateassociations with major cardiac complications for insulintherapy for diabetes (3/59 patients, 5%; relative risk 2.4; 95%TABLE 4. Rates of Major Cardiac Complications and Multivariate ORs* Among Patients With IndividualRisk Factors in Derivation and Validation SetsDerivation Set (n2893)Validation Set (n1422)CrudeDataAdjusted OR(95% CI)CrudeDataAdjusted OR(95% CI)Revised Cardiac Risk Index1. High-risk type of surgery 27/894 (3%) 2.8 (1.6, 4.9) 18/490 (4%) 2.6 (1.3, 5.3)2. Ischemic heart disease 34/951 (4%) 2.4 (1.3, 4.2) 26/478 (5%) 3.8 (1.7, 8.2)3. History of congestive heart failure 23/434 (5%) 1.9 (1.1, 3.5) 19/255 (7%) 4.3 (2.1, 8.8)4. History of cerebrovascular disease 17/291 (6%) 3.2 (1.8, 6.0) 10/140 (7%) 3.0 (1.3, 6.8)5. Insulin therapy for diabetes 7/112 (6%) 3.0 (1.3, 7.1) 3/59 (5%) 1.0 (0.3, 3.8)6. Preoperative serum creatinine 2.0 mg/dL 9/103 (9%) 3.0 (1.4, 6.8) 3/55 (5%) 0.9 (0.2, 3.3)*Based on logistic regression models including these 6 variables.Downloaded from circ.ahajournals.org at UNIV MASSACHUSETTS on January 18, 2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!